Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: Diagnostic and prognostic value

British Journal of Cancer

Volumn 104, Issue 1, 2011, Pages 110-119

  Lomnytska, M I ^a,c   Becker, S ^a   Bodin, I ^a   Olsson, A ^a   Hellman, K ^a   Hellstrom A C ^a   Mints, M ^a   Hellman, U ^b   Auer, G ^a   Andersson, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

cervical cancer precursors; diagnostics; immunohistochemistry; marker protein patterns; squamous cervical cancer

Indexed keywords

CALPHOBINDIN II; HEAT SHOCK PROTEIN 27; PEROXIREDOXIN 2; PROTEIN; PROTEIN NCF2; TROPOMYOSIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INVASION; CANCER RELAPSE; CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ANNEXIN A6; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOPLASM; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; NADPH OXIDASE; NEOPLASM INVASIVENESS; PEROXIREDOXINS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TROPOMYOSIN; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 78650912720     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605992     Document Type: Article

References (45)

1. Alameda F, Espinet B, Corzo C, Munoz R, Bellosillo B, Lloveras B, Pijuan L, Gimeno J, Salido M, Sole F, Carreras R, Serrano S (2009) 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistenceprogression indicator in low-grade squamous intraepithelial lesion cases. Hum Pathol 40: 1474-1478
2. Ammons MC, Siemsen DW, Nelson-Overton LK, Quinn MT, Gauss KA (2007) Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity. J Biol Chem 282: 17941-17952
3. Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin K-L, Ried T, Heselmeyer-Haddad K (2009) Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. Am J Pathol 175: 1831-1847
4. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008) Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 111: 167-177
5. Babés A (1928) Cancer du col uterin par Les-Frottis. Presse Med 29: 451
6. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS (2005) Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99: 26-35
7. Barwise JL, Walker JH (1996) Annexins II, IV, V and VI relocate in human foreskin fibroblasts. J Cell Sci 109: 247-255
8. Bellone S, Frera G, Landolfi G, Romani C, Bandiera E, Tognon G, Roman JJ, Burnett AF, Pecorelli S, Santin AD (2007) Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic disease. Gynecol Oncol 106: 513-520
9. Bharadwaj S, Prasad GL (2002) Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett 26: 205-213
10. Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL (2005) Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene 15: 8291-8303
11. Brismar S, Johansson B, Borjesson M, Arbyn M, Andersson S (2009) Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol 201: 17e1-17e8
12. Buzhynskyy N, Golczak M, Lai-Kee-Him J, Lambert O, Tessier B, Gounou C, Bérat R, Simon A, Granier T, Chevalier JM, Mazères S, Bandorowicz-Pikula J, Pikula S, Brisson AR (2009) Annexin-A6 presents two modes of association with phospholipid membranes: a combined QCM-D, AFM and cryo-TEM study. J Struct Biol 168: 107-116
13. Castellsague X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110: S4-S7
14. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ, Xiao ZQ (2008) Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res 7: 2415-2426
15. Choi YP, Kang S, Hong S, Xie X, Cho NH (2005) Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 5: 1481-1493
16. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103
17. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 191: 969-976
18. Francia G, Mitchell SD, Moss SE, Hanby AM, Marshall JF, Hart IR (1996) Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res 56: 3855-3858
19. Garcia M, Lemal A, Ward EM, Center MM (2007) Global cancer facts and figures. American Cancer Society: Atlanta, GA
20. Gauss KA, Bunger PL, Larson TC, Young CJ, Nelson-Overton LK, Siemsen DW, Quinn MT (2005) Identification of a novel tumor necrosis factor alpha-responsive region in the NCF2 promoter. J Leukoc Biol 77: 267-278
21. Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82: 331-371
22. Glantz S (1998) Medico-Biological Statistics. Medicyna Praktika: Moscow, 128p
23. Helfman DM, Flynn P, Khan P, Saeed A (2008) Tropomyosin as a regulator of cancer cell transformation. Adv Exp Med Biol 644: 124-131
24. Hellman K, Alaiya AA, Becker S, Lomnytska M, Schedvins K, Steinberg W, Hellström AC, Andersson S, Hellman U, Auer G (2009) Differential tissue-specific protein markers of vaginal carcinoma. Br J Cancer 21: 1303-1314
25. Hellman K, Alaiya AA, Schedvins K, Steinberg W, Hellström AC, Auer G (2004) Protein expression patterns in primary carcinoma of the vagina. Br J Cancer 91: 319-326
26. Kulasingam V, Diamandis EP (2008) Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 5: 588-599
27. Lomnytska M, Becker S, Hellman K, Hellström A-C, Souchelnytskyi S, Mints M, Hellman U, Andersson S, Auer G (2010) Diagnostic marker protein patterns in squamous cervical cancer. Proteomics Clin Applications 4: 17-31
28. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M (2004) DNA aneuploidy and integration of human papillomavirus type 16 E6/E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Can Res 10: 3059-3063
29. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527
30. Näslund I, Auer G, Pettersson F, Sjövall K (1986) Evaluation of the pulse wash sampling technique for screening of uterine cervical carcinoma. Acta Radiol Oncol 25: 131-136 (Pubitemid 16061676)
31. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 3: 20-25
32. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ (2001) Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21: 2085-2090
33. Ono A, Kumai T, Koizumi H, Nishikawa H, Kobayashi S, Tadokoro M (2009) Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues. Hum Pathol 40: 41-49
34. Papanicolaou GN (1928) New cancer diagnosis. Proceedings of the Third Race Betterment Conference, pp 528-534
35. Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC (2006) Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11: 269-275
36. Singh M, Mehrotra S, Kalra N, Singh U, Shukla Y (2008) Correlation of DNA ploidy with progression of cervical cancer. J Cancer Epidemiol 2008: 1-7
37. Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME (2008) Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 45: 1178-1189
38. Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Kang SW, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula VL (2006) Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS 114: 329-337
39. Steinbeck RG, Auer G, Zetterberg AD (1999) Reliability and significance of DNA measurements in interphase nuclei and division figures in histological sections. Eur J Cancer 35: 787-795
40. Strzelecka-Kiliszek A, Buszewska ME, Podszywalow-Bartnicka P, Pikula S, Otulak K, Buchet R, Bandorowicz-Pikula J (2008) Calcium-and pH-dependent localization of annexin A6 isoforms in Balb/3T3 fibroblasts reflecting their potential participation in vesicular transport. J Cell Biochem 104: 418-434
41. Sztolsztener ME, Strzelecka-Kiliszek A, Pikula S, Tylki-Szymanska A, Bandorowicz-Pikula J (2009) Cholesterol as a factor regulating intracellular localization of annexin A6 in Niemann-Pick type C human skin fibroblasts. Arch Biochem Biophys 15: 221-233
42. Van den IJssel P, Wheelock R, Prescott A, Russell P, Quinlan RA (2003) Nuclear speckle localisation of the small heat shock protein B-crystallin and its inhibition by the R120G cardiomyopathy-linked mutation. Exp Cell Res 287: 249-261
43. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633-1638
44. Zhu X, Lv J, Yu L, Zhu X, Wu J, Zou S, Jiang S (2009) Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecol Oncol 112: 248-256
45. Zur Hausen H (2009) Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384: 260-265